CJC-1295 + IPAMORELIN PEPTIDE

STRUCTURE AND DETAILED MECHANISM OF ACTION

• CJC-1295 (commonly used in DAC or non-DAC form): A 30-amino acid peptide that mimics GHRH from the hypothalamus. It binds to the GHRH-R receptor on somatotroph cells in the pituitary gland, activating the Gs/cAMP signaling pathway → increasing GH synthesis and secretion.
• Ipamorelin: A 5-amino acid peptide that acts as a ghrelin mimetic. It binds to the ghrelin receptor (GHS-R1a), strongly and rapidly stimulating GH release without significantly increasing cortisol, prolactin, or ACTH (much more selective than GHRP-2 or GHRP-6).

 When combined: Ipamorelin creates a strong and fast GH pulse (peak within 1 hour), while CJC-1295 prolongs and sustains the GH release. The synergistic effect increases GH levels by 3–10 times, sustainably raises IGF-1, and maintains the natural pulsatile rhythm of GH without shutting down the pituitary gland like exogenous HGH.

 DIFFERENCE BETWEEN CJC-1295 WITH DAC AND NO DAC

• CJC-1295 with DAC (Drug Affinity Complex): Long half-life (5–8 days), provides prolonged and steady GH release. Ideal for those who prefer fewer injections (1–2 times per week). Strong cumulative effect and more sustained IGF-1 elevation. However, it may cause more water retention and is less “pulsatile” compared to natural patterns.
• CJC-1295 without DAC (also known as Mod GRF 1-29): Short half-life (about 30 minutes), requires multiple daily injections (2–3 times/day) to create a GH pulse pattern closest to natural physiology. Causes less water retention and is more flexible, but less convenient due to injection frequency.

Most users prefer the CJC with DAC + Ipamorelin blend for convenience, while the non-DAC version is better suited for those wanting to closely mimic the body’s natural GH rhythm.

MAIN BENEFITS OF CJC-1295 + IPAMORELIN

Based on research and real-world application:

• Muscle growth & recovery: Increases protein synthesis, supports lean muscle development, and accelerates post-workout recovery.
• Fat loss & body recomposition: Strongly promotes lipolysis, especially visceral and abdominal fat.
• Deeper sleep: Enhances slow-wave sleep, improving physical and mental recovery.
• Anti-aging & overall health: Boosts collagen production (skin, hair, nails), improves bone density, joint health, energy, and mood.
• Joint & injury support: Increases collagen synthesis and reduces inflammation.
• Enhanced vitality: Improves libido and endurance when stacked with other hormone peptides such as Kisspeptin.

 CLINICAL EVIDENCE AND KEY STUDIES

• CJC-1295: Randomized, double-blind clinical trials (2006) showed that doses of 30–60 mcg/kg increased GH levels for many days, with IGF-1 rising 1.5–3 times and remaining elevated for 9–28 days. Safe in healthy individuals.
• Ipamorelin: Studies from 1999–2000 confirmed strong GH increase with rapid peaks and no significant effect on cortisol or prolactin.
• CJC + Ipamorelin combination: Mechanism data and widespread use in anti-aging medicine demonstrate powerful synergistic effects on elevating GH/IGF-1, improving body composition, sleep quality, and recovery.

 DOSAGE GUIDELINES (Based on Research and Compounding Use)

• CJC-1295 with DAC: 1–2 mg subcutaneously 1–2 times per week.
• CJC-1295 without DAC: 100–200 mcg per injection, 2–3 times per day.
• Ipamorelin: 100–300 mcg per injection (commonly 200 mcg).
• Popular Blend: 100–200 mcg CJC + 100–300 mcg Ipamorelin injected subcutaneously before bedtime (5–7 nights per week). Start with low doses for the first 2–4 weeks, then adjust according to IGF-1 blood tests. Inject in the abdominal area. Typical cycle: 8–12 weeks on, 4–8 weeks off.

 SPECIFIC STACKING DOSAGES

• With Kisspeptin (reproductive hormone balance + GH): Kisspeptin-10: 100–150 mcg in the morning, 2–3 times/week. CJC + Ipamorelin: 100–200 mcg blend before bed.
• With AOD9604 (strong fat loss + body recomposition): CJC + Ipamorelin: standard dose before bed. AOD9604: 300–500 mcg in the morning on an empty stomach.
• With BPC-157 (injury recovery, joints, gut): CJC + Ipamorelin: standard dose. BPC-157: 250–500 mcg/day (split 1–2 times).
• With TB-500 (soft tissue recovery): CJC + Ipamorelin: standard dose. TB-500: 2–5 mg/week (split into 2 doses).

 General stacking advice:

• Do not mix in the same syringe.
• Administer GH peptides at night and Kisspeptin in the morning.
• Start with low doses and monitor IGF-1, glucose, and insulin after 4–6 weeks.

SIDE EFFECTS

CJC-1295 + Ipamorelin is considered safe at therapeutic doses:

• Common mild effects: redness/pain at injection site, facial flushing, transient headache, mild water retention, increased appetite (less than other GHRPs).
• Rare: initial fatigue, dizziness.
• Does not significantly increase cortisol or prolactin. No serious adverse events reported in short-term studies.

IMPORTANT DISCLAIMER: This is not a medicine or drug. CJC-1295 + Ipamorelin is provided for research and compounding purposes only. These peptides have not been approved by the FDA for general therapeutic use. Always consult a qualified physician before using and perform blood tests (IGF-1, GH, glucose, HbA1c) before and during any protocol.

CONCLUSION

CJC-1295 + Ipamorelin is the “golden duo” in peptide therapy, offering the smartest and most physiological approach to activating your body’s natural growth hormone.

Whether your goal is building muscle, losing fat, improving deep sleep, faster recovery, or comprehensive anti-aging, this duo is a reliable choice when used correctly under professional guidance.

Combined with a healthy lifestyle, it is the key to maintaining vitality, health, and peak performance at any age.

For detailed product information, please contact:
JN Beauty Solutions®
Beauty From Science